2026 Innovative Drug Salon Magok for Bio/Healthcare Companies
An opportunity to network with industry experts from Daewoong Pharmaceutical and Samsung Securities while learning the latest bio investment and BD strategies.
- Deadline
- 마감일 원문 확인
This program, hosted by KISED, supports open innovation case studies, bio IPO trends, global BD strategies, and networking. Inquiries can be made at 02-6958-9106.
3-second summary
- Organizer: Korea Institute of Startup & Entrepreneurship Development (KISED)
- Contact: 02-6958-9106
- Support Content: Open innovation case study (Daewoong Pharmaceutical), Bio IPO trends (Samsung Securities), Global BD strategy (GID Partners), Networking
Recommended for
- Recommended for CEOs of bio/healthcare companies interested in open innovation, IPO, and global BD strategies.
Frequently asked questions
How do I apply?
Applications follow the official program notice, which is in Korean. See the source link for the method and receiving office; Beaconoi can prepare an English draft for your review.
Last updated · Source: official program notice
※ Program information is compiled from each institution’s public sources; actual eligibility, amounts and deadlines may change. Always verify against the official notice (in Korean) before applying.